| __timestamp | Bio-Techne Corporation | Eli Lilly and Company |
|---|---|---|
| Wednesday, January 1, 2014 | 106352000 | 4932500000 |
| Thursday, January 1, 2015 | 144969000 | 5037200000 |
| Friday, January 1, 2016 | 162364000 | 5654900000 |
| Sunday, January 1, 2017 | 188462000 | 6070200000 |
| Monday, January 1, 2018 | 210850000 | 4681700000 |
| Tuesday, January 1, 2019 | 240515000 | 4721200000 |
| Wednesday, January 1, 2020 | 255497000 | 5483300000 |
| Friday, January 1, 2021 | 298182000 | 7312800000 |
| Saturday, January 1, 2022 | 349103000 | 6629800000 |
| Sunday, January 1, 2023 | 366887000 | 7082200000 |
| Monday, January 1, 2024 | 389335000 | 8418299999 |
Unleashing insights
In the ever-evolving pharmaceutical landscape, understanding cost structures is crucial. Eli Lilly and Company, a titan in the industry, has consistently maintained a high cost of revenue, peaking at approximately $7.3 billion in 2021. This represents a significant increase of around 48% from 2014. In contrast, Bio-Techne Corporation, a smaller player, has seen its cost of revenue grow by over 266% from 2014 to 2024, reaching nearly $389 million. This stark difference highlights the scale and operational dynamics between a pharmaceutical giant and a biotech innovator. Notably, Eli Lilly's costs dipped in 2018, reflecting strategic adjustments, while Bio-Techne's steady rise underscores its growth trajectory. As we look to the future, these insights offer a window into the financial strategies shaping the pharmaceutical and biotech sectors.
Eli Lilly and Company vs Bristol-Myers Squibb Company: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Eli Lilly and Company vs CRISPR Therapeutics AG
Cost Insights: Breaking Down Eli Lilly and Company and Travere Therapeutics, Inc.'s Expenses
Eli Lilly and Company vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Eli Lilly and Company and Xencor, Inc.
Pfizer Inc. vs Bio-Techne Corporation: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: GSK plc vs Bio-Techne Corporation
Comparing Cost of Revenue Efficiency: Teva Pharmaceutical Industries Limited vs Bio-Techne Corporation
Cost of Revenue Comparison: Viatris Inc. vs Bio-Techne Corporation
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Bio-Techne Corporation
Cost of Revenue Trends: Bio-Techne Corporation vs Corcept Therapeutics Incorporated
Cost of Revenue Trends: Bio-Techne Corporation vs MorphoSys AG